
Opinion|Videos|January 29, 2025
Assessing Treatment Efficacy: Communication with Patients and Caregivers
Author(s)Jose De La Cerda III, MD, MPH
This video segment covers patient selection criteria for different versions of abiraterone, strategies for assessing treatment efficacy and safety, engaging caregivers to monitor compliance and side effects, and navigating insurance challenges to ensure patients receive the recommended version.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do you assess abiraterone efficacy and safety once the treatment is started? What questions should one ask patients?
- How often do you engage caregivers and ask about patient’s treatment compliance or experience with side effects?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
Trial launches of molecular glue degrader plus apalutamide in mCRPC
5








